r.nakamura
TL2 Moderator · Izmir
Contributes reviews on supplier material. Based in Izmir.
Joined 5 April 2025 · last posted 6d
79 posts, newest first. Showing up to 150.
-
[2026 update] Detection wavelength and why 214 nm and 280 nm disagree Replied, post #60 · Analytics › HPLC & UHPLC · 22 Jul 2026 · 7 likes I read post #58 twice before replying, because I had assumed the opposite. Peak purity: a diode-array detector records a spectrum at every time point. If a peak…
-
PIONEER 6 cardiovascular safety, read as a safety trial rather than an efficacy one Replied, post #11 · Compounds › Oral incretins · 20 Jul 2026 · 26 likes The SOUL trial: cardiovascular outcomes trial for oral semaglutide in people with type 2 diabetes and cardiovascular disease or chronic kidney disease. It demonstrates…
-
Prior authorisation: what the criteria usually require — a second dataset Replied, post #42 · Access › Insurance & coverage · 18 Jul 2026 · 0 likes Prior authorisation: pre-approval requirements and how to satisfy them. Most denials cite specific criteria. Understanding the criterion is the first step in satisfying…
-
Follow-up: Comparing two chromatograms from different laboratories, properly Replied, post #59 · Analytics › HPLC & UHPLC · 13 Jul 2026 · 30 likes This follows post #56 rather than contradicting it. Thank you for the correction. I have edited my earlier post with a note rather than silently, so the thread still…
-
Revisiting: PCOS and metabolic overlap: what is and is not studied Replied, post #51 · Clinical › Comorbidities · 7 Jul 2026 · 16 likes Multiple comorbidities: a person with diabetes, kidney disease, and cardiovascular disease is outside the studied populations in most trials. Extrapolating to that…
-
How to ask a question when you cannot say why you are asking it Replied, post #31 · Start Here › How to Ask · 5 Jul 2026 · 0 likes I read post #29 twice before replying, because I had assumed the opposite. Disagreeing with an answer you got: cite what you disagree with, say what contradicts it, and…
-
Reading a rodent study on a secretagogue without over-extrapolating — the long version Replied, post #20 · Compounds › Secretagogues & GH axis · 3 Jul 2026 · 0 likes Why this subcategory is stricter about sourcing than most: the evidence base is weaker and that is precisely why documentation quality matters more. A supplier page…
-
Journal club: STEP 1 and the treatment-policy estimand — does this still hold? Replied, post #54 · Evidence › Journal club · 30 Jun 2026 · 1 like STEP 1 (N Engl J Med 2021): The pivotal obesity trial for semaglutide and the reference point for most subsequent comparison. Mean weight reduction was substantially…
-
Sleep apnoea improving and the equipment implications Replied, post #10 · Wellbeing › Sleep · 30 Jun 2026 · 24 likes post #9 is right about the mechanism and I think understates the practical bit. Gastrointestinal effects overnight: nausea or reflux or constipation at night can…
-
Packaging that arrived damaged: documenting it properly Replied, post #31 · Sourcing › Logistics · 25 Jun 2026 · 1 like Customs outcomes are not predictable at the level of an individual parcel. What is predictable is that consistent, accurate declarations correlate with fewer…
-
What published stability data actually covers, and what it does not Replied, post #7 · Practice › Storage & stability · 21 Jun 2026 · 8 likes For anyone arriving from a search: the marked solution above is the direct answer, and the replies underneath it add the caveats that make it safe to use.
-
Secretagogues and glucose tolerance: the mechanistic concern Replied, post #19 · Compounds › Secretagogues & GH axis · 31 May 2026 · 6 likes Why this subcategory is stricter about sourcing than most: the evidence base is weaker and that is precisely why documentation quality matters more. A supplier page…
-
[2026 update] Regional warehouse stock versus direct despatch Replied, post #84 · Sourcing › Logistics · 29 May 2026 · 32 likes post #83 answers the question as asked. The question underneath it is different. Declaring contents accurately: declaring accurately reduces intervention risk. A…
-
About the Interactions category Replied, post #9 · Practice › Interactions · 18 May 2026 · 26 likes I read post #7 twice before replying, because I had assumed the opposite. Sulfonylureas and meglitinides: these agents stimulate insulin release and carry hypoglycemia…
-
Reading a trial's population section before its results Replied, post #29 · Evidence › Trials · 17 May 2026 · 24 likes Intent-to-treat versus per-protocol: ITT includes everyone assigned regardless of whether they took the drug. Per-protocol includes only those who completed it as…
-
Transporting a vial for a weekend away — a second dataset Replied, post #52 · Practice › Storage & stability · 13 May 2026 · 5 likes Freeze-thaw: some peptide solutions tolerate freezing poorly because ice crystals damage protein structure. Whether your specific solution tolerates it depends on the…
-
Why retatrutide discussion here is more cautious than elsewhere Replied, post #10 · Compounds › Retatrutide · 5 May 2026 · 0 likes post #9 is right about the mechanism and I think understates the practical bit. The phase 2 obesity paper reported dose-dependent weight reduction of a magnitude that…
-
Research-use-only status: what it means legally and practically Replied, post #32 · Compounds › Other compounds · 24 Apr 2026 · 15 likes I read post #30 twice before replying, because I had assumed the opposite. Two things before anyone answers the substance. First, the context in the first post is clear…
-
Two scans six weeks apart on different machines: a cautionary tale Replied, post #4 · Outcomes › Body composition · 21 Apr 2026 · 3 likes Maintenance phase: tracking body composition during maintenance (weight stable) is different from tracking during active loss. Changes are smaller and precision becomes…
-
Follow-up: The retatrutide phase 2 obesity paper, read closely Replied, post #10 · Compounds › Retatrutide · 19 Apr 2026 · 28 likes This follows post #7 rather than contradicting it. What we do not know about retatrutide, listed explicitly: long-term safety, real-world response rates, the dose…
-
Converting between mg/mL and units per dose, both directions — the long version Replied, post #12 · Practice › Reconstitution · 17 Apr 2026 · 3 likes On post #8 — agreed on the reasoning, with one qualification. How much of the diluent volume the powder itself displaces: for a small peptide vial, the powder volume is…
-
Spike-and-recover accuracy for a peptide assay Replied, post #38 · Analytics › Method validation · 8 Apr 2026 · 0 likes I disagree with the reply above, and I think the disagreement is substantive rather than terminological. The distinction being drawn does not survive when you look at…
-
Foaming during reconstitution and whether it matters — the long version Replied, post #76 · Practice › Reconstitution · 26 Mar 2026 · 0 likes The decimal-point error: computing 5 mg / 2 mL as 0.25 mg/mL instead of 2.5 mg/mL is the most common arithmetic error in this subcategory. The habit that catches it:…
-
Grapefruit: why this class is not the class that cares Replied, post #73 · Practice › Interactions · 24 Mar 2026 · 0 likes Metformin: commonly co-administered and relevant to gastrointestinal tolerability. Gastrointestinal side effects can overlap and additive. Taking them separately or…
-
Coming back to: Why most self-reports here are not experiments, and that is fine Replied, post #49 · Research Methods › N-of-1 designs · 25 Feb 2026 · 1 like Worth separating two things that post #45 runs together. Statistical analysis of n-of-1 data: comparing before versus after with a t-test or similar is one approach.…
-
Seven-day rolling means and why weekly readings mislead — one year on Replied, post #27 · Outcomes › Progress reports · 10 Feb 2026 · 0 likes Picking up post #24: that is the part I would want checked first. Thank you for the correction. I have edited my earlier post with a note rather than silently, so the…
-
Packaging that arrived damaged: documenting it properly — a second dataset Replied, post #34 · Sourcing › Logistics · 6 Feb 2026 · 0 likes Picking up post #31: that is the part I would want checked first. Cold packs and temperature control: inclusion of cold packs at despatch is standard. Whether they…
-
Pre-registering a personal experiment, seriously — a second dataset Replied, post #23 · Research Methods › N-of-1 designs · 21 Jan 2026 · 6 likes post #22 answers the question as asked. The question underneath it is different. Generalisability: a robust n-of-1 result applies to you. It does not tell you much…
-
Analytical identity of BPC-157: a 15-mer with a simple mass — does this still hold? Replied, post #2 · Compounds › Repair & healing peptides · 26 Dec 2025 · 9 likes Worth separating two things that the opening post runs together. BPC-157: the preclinical literature is extensive, mostly from a small number of research groups, and…
-
Reconstitution volumes that produce round numbers, tabulated Replied, post #3 · Practice › Reconstitution · 1 Dec 2025 · 0 likes Two things before anyone answers the substance. First, the context in the first post is clear and specific. Second, the question is framed so that an answer can…
-
Pharmaceutical compounding rules, summarised from primary sources — a second dataset Replied, post #53 · Sourcing › Regulatory · 28 Nov 2025 · 0 likes Worth separating two things that post #49 runs together. Preclinical versus clinical: compounds with strong preclinical data can fail in clinical trials. Compounds with…
-
Can a home kit substitute for a laboratory report? A careful no Replied, post #54 · Analytics › Home & field testing · 15 Nov 2025 · 0 likes False positives and false negatives: no test has 100% sensitivity and 100% specificity. A negative result does not guarantee absence; a positive result does not…
-
Thyroid function tests during substantial weight change Replied, post #117 · Clinical › Bloodwork · 1 Nov 2025 · 1 like post #116 answers the question as asked. The question underneath it is different. Fasting state: some lab tests require fasting; others do not. Lipids on a fasting draw…
-
Absence of evidence and evidence of absence Replied, post #3 · Research Methods › Statistics · 22 Oct 2025 · 1 like Multiplicity and multiple comparisons: if you test many hypotheses, the chance of finding a false positive by random chance increases. That is why pre-specifying the…
-
A 40-week log with the measurement method stated Replied, post #5 · Outcomes › Progress reports · 12 Oct 2025 · 5 likes Plateaus and resets: if weight loss stalls and then resumes, that is ordinary. It is not evidence that the medication stopped working. It is not evidence that it is…
-
Specification in the result column: why that is a meaningful error Replied, post #56 · Analytics › COA interpretation · 10 Oct 2025 · 0 likes This follows post #53 rather than contradicting it. A certificate of analysis is a statement by its issuer that a defined test was performed on a defined lot and…
-
A parcel that arrived warm: a decision process, not a verdict Replied, post #41 · Practice › Storage & stability · 17 Sep 2025 · 0 likes I read post #39 twice before replying, because I had assumed the opposite. Container choice matters: the material of the vial, the rubber closure, the fill volume all…
-
"Greater than or equal to 99%" as a specification rather than a result Replied, post #33 · Analytics › COA interpretation · 10 Sep 2025 · 7 likes post #32 is right about the mechanism and I think understates the practical bit. Water content (residual moisture) matters: lyophilised peptide is not dry. A few…
-
Aggregated purity results across four services, with caveats — a second dataset Replied, post #41 · Data & Tools › Datasets · 8 Sep 2025 · 23 likes Limitations of datasets: all community-collected data has limitations. The population is self-selected (people in this community are not representative of all people…
-
Asking about a compound your prescriber has not heard of Replied, post #124 · Clinical › Prescriber conversations · 13 Aug 2025 · 16 likes On post #120 — agreed on the reasoning, with one qualification. Discussing off-label dosing: if you want to dose differently than the label specifies (slower titration,…
-
How to research a compound with no human data without deceiving yourself Replied, post #29 · Compounds › Other compounds · 31 Jul 2025 · 3 likes How to research a compound with no human data: mechanistic plausibility is one input. Preclinical data is another. The honest position is that you are reasoning from…
-
Second pass at: Why this subcategory is stricter about sourcing than most Replied, post #17 · Compounds › Secretagogues & GH axis · 28 Jul 2025 · 31 likes For anyone arriving from a search: the marked solution above is the direct answer, and the replies underneath it add the caveats that make it safe to use.
-
Are there stupid questions here? A staff answer, at length Replied, post #8 · Start Here › Welcome · 23 Jul 2025 · 19 likes Picking up post #5: that is the part I would want checked first. The compound and evidence pages are updated regularly and they are worth reading when you are new. They…
-
Escalating every six weeks instead of four: what I observed over eight months — one year… Replied, post #43 · Practice › Dosing & titration · 21 Jul 2025 · 0 likes Steady state means the plasma concentration is stable from dose to dose. That happens around 4 to 5 half-lives. Before that, the concentration is rising with each dose.…
-
What this community means by "a source", in practical terms Replied, post #24 · Start Here › Welcome · 4 Jul 2025 · 6 likes I read post #22 twice before replying, because I had assumed the opposite. Your introduction is well framed. You have given enough context that people can actually…
-
Coming back to: Why semaglutide solutions can look faintly opalescent and when that… Replied, post #16 · Compounds › Semaglutide · 4 Jul 2025 · 24 likes post #15 answers the question as asked. The question underneath it is different. Albumin binding is not a unique structural feature and nothing in the class lacks it,…
-
A comparison of home results against a laboratory result on the same vial Replied, post #9 · Analytics › Home & field testing · 28 Jun 2025 · 3 likes post #8 answers the question as asked. The question underneath it is different. What you can use home tests for: confirmation that a solution contains peptide (as…
-
Coming back to: What published stability data actually covers, and what it does not Replied, post #72 · Practice › Storage & stability · 26 Jun 2025 · 0 likes Refrigeration slows degradation. Repeated warming and cooling is worse than continuous refrigeration. Light exposure is worth avoiding. The concentration matters…
-
Reading a rodent study on a secretagogue without over-extrapolating Replied, post #15 · Compounds › Secretagogues & GH axis · 14 Jun 2025 · 11 likes Having read the exchange above, I think I was wrong earlier in this topic and I want to say so plainly rather than quietly editing. The correction was fair and I had…
-
Pre-registering a personal experiment, seriously Replied, post #50 · Research Methods › N-of-1 designs · 30 May 2025 · 1 like For anyone arriving from a search: the marked solution above is the direct answer, and the replies underneath it add the caveats that make it safe to use.
-
Specification in the result column: why that is a meaningful error Replied, post #4 · Analytics › COA interpretation · 29 May 2025 · 8 likes Sterility testing is separate: chromatographic purity, mass spectrometry, and endotoxin testing all say nothing about whether a solution is sterile. If sterility…
-
Publishing an inconvenient result: a case study Replied, post #24 · Sourcing › Independent verification · 24 May 2025 · 0 likes Coming back to post #22, because the follow-up matters more than the original answer. VendorInvestigate: documentation and supplier-practice review. Reviews paperwork…
-
Subcutaneous absorption kinetics and site differences Replied, post #4 · Pharmacology › Pharmacokinetics · 21 May 2025 · 26 likes SNAC (the oral bioavailability enhancer): sodium N-(8-[2-hydroxybenzoyl]amino) caprylate transiently raises gastric pH and promotes absorption. Without it, oral…
-
DXA precision and the least significant change for lean mass — the long version Replied, post #66 · Outcomes › Body composition · 19 May 2025 · 0 likes Lean mass loss during rapid weight reduction: depends on protein intake, resistance training volume, and total energy deficit. Adequate protein and maintaining training…
-
Follow-up: Tesamorelin has an approved indication — what that changes about the evidence Replied, post #61 · Compounds › Secretagogues & GH axis · 13 May 2025 · 0 likes This follows post #58 rather than contradicting it. Reading a rodent study on a secretagogue without over-extrapolating: rodent studies can show a mechanism is…
-
Hepatic steatosis: what the MASH trial evidence supports Replied, post #37 · Clinical › Comorbidities · 10 May 2025 · 16 likes Picking up post #34: that is the part I would want checked first. I disagree with the reply above, and I think the disagreement is substantive rather than…
-
Follow-up: History of disordered eating and why it changes the conversation Replied, post #5 · Clinical › Special populations · 5 May 2025 · 1 like post #4 is right about the mechanism and I think understates the practical bit. Pregnancy and planning: these compounds are not approved for use in pregnancy. Planning…
-
Validating a calculator against hand arithmetic — what changed since Replied, post #34 · Data & Tools › Calculators · 26 Apr 2025 · 31 likes For anyone arriving from a search: the marked solution above is the direct answer, and the replies underneath it add the caveats that make it safe to use.
-
When to suspect the method rather than the sample Replied, post #97 · Analytics › Method validation · 14 Mar 2025 · 21 likes Precision and repeatability: within-run and between-run variability of the method. Acceptance criterion is typically a relative standard deviation of ≤2% for area…
-
[2026 update] Mood changes: monitoring, and when to involve a professional Started this topic · Wellbeing › Mental health · 15 Jan 2025 · 15 likes Posting this under the heading it deserves: Mood changes: monitoring, and when to involve a professional Everything below is what sits behind that. General question,…
-
Second pass at: Historical amylin analogues and what happened to them Replied, post #11 · Compounds › Cagrilintide & amylin analogues · 13 Jan 2025 · 1 like I disagree with the reply above, and I think the disagreement is substantive rather than terminological. The distinction being drawn does not survive when you look at…
-
Dose numbers for oral formulations are not comparable to injectable ones — a second… Replied, post #14 · Compounds › Oral incretins · 2 Jan 2025 · 0 likes Coming back to post #12, because the follow-up matters more than the original answer. Trial adherence in an oral trial with strict administration requirements is…
-
Isotonicity and what happens when you get it wrong Replied, post #15 · Pharmacology › Formulation chemistry · 2 Jan 2025 · 16 likes Two things before anyone answers the substance. First, the context in the first post is clear and specific. Second, the question is framed so that an answer can…
-
Body image changing more slowly than the body Replied, post #123 · Wellbeing › Mental health · 24 Dec 2024 · 2 likes Picking up post #120: that is the part I would want checked first. Mood and anxiety: mood changes and anxiety are reported by some people. Baseline mental health status…
-
What we do not know about retatrutide, listed explicitly Replied, post #31 · Compounds › Retatrutide · 24 Dec 2024 · 26 likes Phase 2 sample sizes are not adequate for safety characterisation of a novel triple agonist. Phase 3 is where that question gets answered. Using phase 2 results to make…
-
Criticising the method without criticising the authors Replied, post #26 · Evidence › Study critique · 23 Dec 2024 · 0 likes Building consensus on which criticisms matter: if everyone agrees that the sample size is small but only you think that affects the conclusion, maybe your criticism is…
-
Molecular mass of semaglutide and why the figure differs between sources — does this… Replied, post #26 · Compounds › Semaglutide · 20 Dec 2024 · 31 likes Practical note that does not fit anywhere else. Whatever you conclude from this topic, write down what you did and when. The single most useful thing in your own…
-
Meeting a protein target on a suppressed appetite — does this still hold? Replied, post #60 · Nutrition & Training › Protein & intake · 16 Dec 2024 · 18 likes post #59 is right about the mechanism and I think understates the practical bit. Meeting protein targets on suppressed appetite: this is where the practical difficulty…
-
How to ask for a dose change without antagonising anyone — what changed since Replied, post #48 · Clinical › Prescriber conversations · 10 Nov 2024 · 8 likes Practical note that does not fit anywhere else. Whatever you conclude from this topic, write down what you did and when. The single most useful thing in your own…
-
Time to steady state after a dose increase Replied, post #147 · Pharmacology › Pharmacokinetics · 6 Nov 2024 · 5 likes Worth separating two things that post #143 runs together. Half-life: semaglutide ≈ 165–184 hours (about a week). Tirzepatide ≈ 5 days. Liraglutide ≈ 13 hours. The…
-
Second pass at: A field-by-field walk through a certificate of analysis Replied, post #101 · Analytics › COA interpretation · 30 Oct 2024 · 0 likes Thank you for the correction. I have edited my earlier post with a note rather than silently, so the thread still makes sense to read. The error was mine and it was the…
-
Criticising the method without criticising the authors Replied, post #10 · Evidence › Study critique · 11 Oct 2024 · 1 like Criticise the method, not the author: a paper with a weak design is not a bad paper by someone with bad intentions. It is a paper that answers a limited question.…
-
Coming back to: Grapefruit: why this class is not the class that cares Replied, post #13 · Practice › Interactions · 2 Oct 2024 · 11 likes Metformin: commonly co-administered and relevant to gastrointestinal tolerability. Gastrointestinal side effects can overlap and additive. Taking them separately or…
-
What a stability-indicating method is and how you demonstrate one — one year on Replied, post #30 · Analytics › Method validation · 10 Sep 2024 · 0 likes Range: the concentration range over which the method has been validated. Going outside the validated range is going outside the method's demonstrated performance.
-
Splitting a vial for two laboratories: how to do it without ruining both — what changed… Replied, post #28 · Sourcing › Independent verification · 31 Aug 2024 · 2 likes Practical note that does not fit anywhere else. Whatever you conclude from this topic, write down what you did and when. The single most useful thing in your own…
-
Promotion criteria, and the one that stops most nominations Replied, post #46 · Documentation › Doc review · 25 Aug 2024 · 18 likes I disagree with the reply above, and I think the disagreement is substantive rather than terminological. The distinction being drawn does not survive when you look at…
-
Circumference measurements as a poor man's composition estimate Replied, post #49 · Outcomes › Body composition · 7 Aug 2024 · 30 likes Bioelectric impedance analysis: less precise than DXA and strongly affected by hydration state. Not reliable for detecting month-to-month changes. Useful for trend over…
-
Second pass at: Retatrutide dose escalation in the published trials Replied, post #80 · Compounds › Retatrutide · 21 Jul 2024 · 2 likes Mass and identity: a report on retatrutide should state the mass detected by LC-MS, not assume a theoretical mass. The theoretical mass is not published in…
-
Assessing a warm arrival: the decision process — one year on Replied, post #101 · Sourcing › Logistics · 1 Jun 2024 · 28 likes post #100 is right about the mechanism and I think understates the practical bit. At what point is a parcel genuinely a problem: if it was despatched weeks ago and…